{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:29Z","timestamp":1792083629798,"version":"4.4.0"},"reference-count":65,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009742","name":"Dr \u00c5ke Olssons Stiftelse f\u00f6r Haematologisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009781","name":"Robert Lundbergs Minnesstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polo\u2010like kinase 1 (PLK1) is an important cell cycle kinase and an attractive target for anticancer treatments. An ATP\u2010competitive small molecular PLK1 inhibitor, volasertib, has reached phase III in clinical trials in patients with refractory acute myeloid leukemia as a combination treatment with cytarabine. However, severe side effects limited its use. The origin of the side effects is unclear and might be due to insufficient specificity of the drug. Thus, identifying potential off\u2010targets to volasertib is important for future clinical trials and for the development of more specific drugs. In this study, we used thermal proteome profiling (TPP) to identify proteome\u2010wide targets of volasertib. Apart from PLK1 and proteins regulated by PLK1, we identified about 200 potential volasertib off\u2010targets. Comparison of this result with the mass\u2010spectrometry analysis of volasertib\u2010treated cells showed that phosphatidylinositol phosphate and prostaglandin metabolism pathways are affected by volasertib. We confirmed that PIP4K2A and ZADH2\u2014marker proteins for these pathways\u2014are, indeed, stabilized by volasertib. PIP4K2A, however, was not affected by another PLK1 inhibitor onvansertib, suggesting that PIP4K2A is a true off\u2010target of volasertib. Inhibition of these proteins is known to impact both the immune response and fatty acid metabolism and could explain some of the side effects seen in volasertib\u2010treated patients.<\/jats:p>","DOI":"10.1096\/fj.202100457rr","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:26:42Z","timestamp":1624012002000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Thermal proteome profiling identifies PIP4K2A and ZADH2 as off\u2010targets of Polo\u2010like kinase 1 inhibitor volasertib"],"prefix":"10.1096","volume":"35","author":[{"given":"Oksana","family":"Goroshchuk","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Kolosenko","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kunold","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2010Pathology Clinical Proteomics Mass Spectrometry Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vidarsdottir","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Pirmoradian","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2010Pathology Clinical Proteomics Mass Spectrometry Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Azimi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-4709","authenticated-orcid":false,"given":"Rozbeh","family":"Jafari","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2010Pathology Clinical Proteomics Mass Spectrometry Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-2099","authenticated-orcid":false,"given":"Caroline","family":"Palm\u2010Apergi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Biomolecular and Cellular Medicine Karolinska Institutet Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0443-5"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/children2010001"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.14.16494"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0128"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2015.03.010"},{"key":"e_1_2_10_7_1","unstructured":"Results of Phase III study of volasertib for the treatment of acute myeloid leukemia presented at European Hematology Association Annual Meeting. Boehringer\u2010Ingelheim."},{"key":"e_1_2_10_8_1","article-title":"Volasertib, a potential new treatment for rhabdomyosarcoma, receives Orphan Drug Designation from the U.S. FDA","author":"Oncoheroes Biosciences Inc.","year":"2020","journal-title":"Oncoheroes Biosci"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2445"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.138"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3652"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233606"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.07.002"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20145625"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2732"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.101"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.TIR119.001481"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1324s46"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6277"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr400937n"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3134"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-163"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.03.054"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59653-5"},{"key":"e_1_2_10_26_1","unstructured":"BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours\u2014Full Text View\u2014ClinicalTrials.gov."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.TIR119.001646"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.044321"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1157425"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_2_10_31_1","unstructured":"KEGG: Kyoto Encyclopedia of Genes and Genomes."},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2019.11.010"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.108.134973"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1194"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1193-4"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002454RR"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.084"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182210"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2015.06.014"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.02.003"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.057"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2019.04.002"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20172170"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2015.02.014"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058424"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0765"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-560557"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600934113"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2006.12.037"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4368"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2007.00594.x"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.175"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1976.99"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M037556"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005619"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02390314"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.144"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005602"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2008.09.007"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.073080"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.11.016"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.07.002"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1395"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr5002516"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202100457RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.202100457RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202100457RR","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:56:40Z","timestamp":1773237400000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202100457RR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1096\/fj.202100457RR"],"URL":"https:\/\/doi.org\/10.1096\/fj.202100457rr","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"2021-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e21741"}}